nasal vaccine BBV154 Current Affairs, GK & News

India’s first intra-nasal Corona vaccine: GK & Current Affairs Facts

The country’s first intranasal COVID vaccine iNCOVACC by Bharat Biotech has recently received DCGI approval for primary immunization against the infection for people above the age of 18 years. This vaccine has been named ChAd36-SARS-CoV-S COVID-19. Highlights ChAd36-SARS-CoV-S COVID-19 (Chimpanzee Adenovirus Vectored) Recombinant Nasal Vaccine for COVID-19 by Bharat Biotech is the first of its ..

Month: 

Category: 

Topics: 

Bharat Biotech’s intranasal vaccine – Update

Bharat Biotech recently sought approval for its intranasal Covid vaccine candidate, BBV154, as two-dose vaccine as well as booster dose. It submitted data from Phase 3 clinical trials of BBV154 to seek approval. Highlights: The heterologous booster infers that, third or subsequent dose of the vaccine is not similar to its primary dose. Usually, primary doses include two ..

Month: 

Category: 

Topics: 

Nasal Covid Vaccine Gets Regulatory Nod for further trials

India’s first nasal vaccine against COVID-19 has received the nod to conduct phase 2 and 3 clinical trials by the Department of Biotechnology. Key Points Nasal Covid Vaccine has been developed by Bharat Biotech. Vaccine has successfully completed Phase 1 clinical trial in age groups of 18 to 60 years. According to the officials, doses ..

Month: 

Category: 

Topics: